APA (7th ed.) Citation

He, Z., He, W., Wu, L., Zhao, C., Peng, N., Ahir, B., & Lu, C. (2017). Letter: Cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Alimentary Pharmacology & Therapeutics, 45(1), 183. https://doi.org/10.1111/apt.13820

Chicago Style (17th ed.) Citation

He, Z.‐H, W.‐R He, L.‐L Wu, C. Zhao, N.‐F Peng, B.‐K Ahir, and C.‐Y Lu. "Letter: Cytokeratin-18 as a Biomarker of Hepatocellular Carcinoma Regression After Transarterial Chemoembolization." Alimentary Pharmacology & Therapeutics 45, no. 1 (2017): 183. https://doi.org/10.1111/apt.13820.

MLA (9th ed.) Citation

He, Z.‐H, et al. "Letter: Cytokeratin-18 as a Biomarker of Hepatocellular Carcinoma Regression After Transarterial Chemoembolization." Alimentary Pharmacology & Therapeutics, vol. 45, no. 1, 2017, p. 183, https://doi.org/10.1111/apt.13820.